124845-04-1

Basic information

• Product Name: 5-CYCLOPROPYLISOXAZOLE-4-CARBOXYLIC ACI&
• Synonyms: 4-Isoxazolecarboxylicacid,5-cyclopropyl-(9CI);5-cyclopropyl-1,2-oxazole-4-carboxylic acid;5-CYCLOPROPYLISOXAZOLE-4-CARBOXYLIC ACI&
• CAS NO: 124845-04-1
• Molecular Formula: C₇H₇NO₃
• Molecular Weight: 153.136
• Product Categories: CARBOXYLICACID;OXAZOLE;Building Blocks;Heterocyclic Building Blocks;Isoxazoles;Building Blocks;Chemical Synthesis;Heterocyclic Building Blocks;carboxylic acid
• Mol File: 124845-04-1.mol
• Article Data: 5

Chemical Properties

• Melting Point: 161-165 °C(lit.)
• Boiling Point: 317.6°C at 760 mmHg
• Flash Point: 145.9°C
• Appearance: /
• Density: 1.445g/cm³
• Vapor Pressure: 0.000159mmHg at 25°C
• Refractive Index: 1.586
• CAS DataBase Reference: 5-CYCLOPROPYLISOXAZOLE-4-CARBOXYLIC ACI&(CAS DataBase Reference)
• NIST Chemistry Reference: 5-CYCLOPROPYLISOXAZOLE-4-CARBOXYLIC ACI&(124845-04-1)
• EPA Substance Registry System: 5-CYCLOPROPYLISOXAZOLE-4-CARBOXYLIC ACI&(124845-04-1)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• WGK Germany: 3
• Hazardous Substances Data: 124845-04-1(Hazardous Substances Data)

Usage

General Description

5-Cyclopropylisoxazole-4-carboxylic acid is a chemical compound with the molecular formula C6H7NO3 and a molecular weight of 141.12 g/mol. It is a carboxylic acid derivative containing a cyclopropylisoxazole ring, which has potential applications in the pharmaceutical industry. 5-CYCLOPROPYLISOXAZOLE-4-CARBOXYLIC ACI& has been studied for its antimicrobial and antifungal properties, and it has also been investigated as a potential building block for the synthesis of various pharmaceutical compounds. Additionally, 5-Cyclopropylisoxazole-4-carboxylic acid has been studied for its potential as a modulator of the central nervous system, specifically in relation to the treatment of neurodegenerative disorders. Overall, this chemical compound has potential applications in drug discovery and development, particularly in the fields of antimicrobial, antifungal, and neurological pharmacology.

InChI:InChI=1/C7H7NO3/c9-7(10)5-3-8-11-6(5)4-1-2-4/h3-4H,1-2H2,(H,9,10)

Upstream product

• 32249-35-7 methyl 3-cyclopropyl-3-oxopropanoate 
• 4637-24-5 N,N-dimethyl-formamide dimethyl acetal 

Downstream Products

• 124844-97-9 5-cyclopropyl-N-(4-(trifluoromethyl)phenyl)isoxazole-4-carboxamide 

Relevant articles and documents

Design, Synthesis, and Herbicidal Activity of N-Benzyl-5-cyclopropyl-isoxazole-4-carboxamides

Based on the structures of isoxaflutole (IFT) and N-isobutyl-N-(4-chloro-benzyl)-4-chloro-2-pentenamide, a series of N-benzyl-5-cyclopropyl-isoxazole-4-carboxamides was designed by connecting their pharmacophores (i.e., a multitarget drug design strategy). A total of 27 N-benzyl-5-cyclopropyl-isoxazole-4-carboxamides were prepared from 5-cyclopropylisoxazole-4-carboxylic acid and substituted benzylamines, and their structures were confirmed by NMR and MS. Laboratory bioassays indicated that I-26 showed 100% inhibition against Portulaca oleracea and Abutilon theophrasti at a concentration of 10 mg/L, better than the positive control butachlor (50% inhibition for both weeds). A strong growth inhibition was observed, but a typical bleaching phenomenon of IFT could not be observed in the Petri dish assay. I-05 displayed excellent postemergence herbicidal activity against Echinochloa crusgalli and A. theophrasti at a rate of 150 g/ha, and bleaching symptoms were observed in the leaves of treated weeds. The bleaching effect of Chlamydomonas reinhardtii treated by I-05 could be reversed by adding homogentisate. Enzymatic bioassays indicated that I-05 could not inhibit 4-hydroxyphenylpyruvate dioxygenase (HPPD) activity, but II-05, an isoxazole ring-opening product of I-05, could inhibit HPPD activity with an EC50 value of 1.05 μM, similar to that of mesotrione (with an EC50 value of 1.35 μM). Detailed discussion about observed herbicidal symptoms is provided in the Results and Discussion section. This investigation provided a proof-of-concept foundation that a multitarget drug design strategy could be applied in agrochemical research.

SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF 11BETA-HSD-1

Compounds of formula I and IV are described and have therapeutic utility, particularly in the treatment of diabetes, obesity and related conditions and disorder: wherein the variables A-B, R1, R2, m, and Q are described herein.

Antiarthritic β-cycloalkyl-β-oxopropionitriles

Disclosed herein are novel β-cycloalkyl-β-oxopropionitriles which exhibit anti-inflammatory/antiarthritic activities.